Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.720
+0.040 (1.49%)
At close: Nov 7, 2025, 4:00 PM EST
2.770
+0.050 (1.84%)
After-hours: Nov 7, 2025, 8:00 PM EST
Stereotaxis Revenue
Stereotaxis had revenue of $8.80M in the quarter ending June 30, 2025, with 95.42% growth. This brings the company's revenue in the last twelve months to $31.81M, up 33.94% year-over-year. In the year 2024, Stereotaxis had annual revenue of $26.92M with 0.55% growth.
Revenue (ttm)
$31.81M
Revenue Growth
+33.94%
P/S Ratio
7.45
Revenue / Employee
$228,820
Employees
139
Market Cap
247.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.92M | 147.00K | 0.55% |
| Dec 31, 2023 | 26.77M | -1.38M | -4.89% |
| Dec 31, 2022 | 28.15M | -6.87M | -19.63% |
| Dec 31, 2021 | 35.02M | 8.39M | 31.51% |
| Dec 31, 2020 | 26.63M | -2.27M | -7.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
STXS News
- 17 days ago - Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025 - GlobeNewsWire
- 23 days ago - Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs - GlobeNewsWire
- 25 days ago - Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias - GlobeNewsWire
- 6 weeks ago - Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System - GlobeNewsWire
- 2 months ago - First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter - GlobeNewsWire
- 2 months ago - Stereotaxis to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025 - GlobeNewsWire
- 3 months ago - Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript - Seeking Alpha